User menu

Hypoglycaemic effect of AICAriboside in mice.

Bibliographic reference Vincent, Marie-Françoise ; Erion, M D ; Gruber, H E ; Van den Berghe, Georges. Hypoglycaemic effect of AICAriboside in mice.. In: Diabetologia, Vol. 39, no. 10, p. 1148-55 (1996)
Permanent URL
  1. Vincent M. F., Marangos P. J., Gruber H. E., van den Berghe G., Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat Hepatocytes, 10.2337/diab.40.10.1259
  2. Sabina R., Holmes E., Becker M., The enzymatic synthesis of 5-amino-4-imidazolecarboxamide riboside triphosphate (ZTP), 10.1126/science.6199843
  3. Sherratt HS (1981) Inhibition of gluconeogenesis by non-hormonal hypoglycaemic compounds. In: Hue L, van de Werve G (eds) Short-term regulation of liver metabolism. Elsevier/North-Holland, Amsterdam, pp 199–227
  4. Wollenberger Albert, Ristau Otto, Schoffa Georg, Eine einfache Technik der extrem schnellen Abk�hlung gr��erer Gewebest�cke, 10.1007/bf00362995
  5. Hohorst Hans-Jürgen, l-(+)-Lactate, Methods of Enzymatic Analysis (1965) ISBN:9780123956309 p.266-277, 10.1016/b978-0-12-395630-9.50058-x
  6. Lamprecht W, Heinz F (1985) D-Glycerate 2-phosphate and phosphoenol-pyruvate. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 3rd edn, vol 6. Chemi, Weinheim, pp 555–561
  7. Czok R (1985) D-Glycerate 3-phosphate. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 3rd edn, vol 6. Chemie, Weinheim, pp 537–541
  8. Michal G (1985) D-fructose-1,6-diphosphate, dihydroxyacetone phosphate and D-glyceraldehyde-3-phosphate. In: Bergmeyer HU (ed) Methods of enzymatic analysis, 3rd edn, vol 6. Chemie, Weinheim, pp 342–350
  9. Huggett A St G, Nixon DA (1957) Enzymic determination of blood glucose. Biochem J 66:12P
  10. Maes M., Ketelslegers J.-M., Underwood L. E., Low Plasma Somatomedin-C in Streptozotocin-induced Diabetes Mellitus: Correlation with Changes in Somatogenic and Lactogenic Liver Binding Sites, 10.2337/diab.32.11.1060
  11. Elliott Jennifer, Hems D. A., Beloff-Chain Anne, Carbohydrate metabolism of the isolated perfused liver of normal and genetically obese–hyperglycaemic (ob/ob) mice, 10.1042/bj1250773
  12. Assimacopoulos-Jeannet F, Exton JH, Jeanrenaud B (1973) Control of gluconeogenesis and glycogenolysis in perfused livers of normal mice. Am J Physiol 225:25–32
  13. Claus TH, El-Maghrabi MR, Pilkis SJ (1979) Modulation of the phosphorylation state of rat liver pyruvate kinase by allosteric effectors and insulin. J Biol Chem 254:7855–7864
  14. Van Schaftingen E, Hue L, Hers H G, Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liverin vivo, 10.1042/bj1920263
  15. Dixon Ross, Gourzis James, McDermott Daniel, Fujitaki James, Dewland Peter, Gruber Harry, AICA-Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine-Regulating Agent, 10.1002/j.1552-4604.1991.tb03715.x
  16. Menasché Philippe, Jamieson W.R. Eric, Flameng Willem, Michael K. Davies, Acadesine: A new drug that may improve myocardial protection in coronary artery bypass grafting, 10.1016/s0022-5223(05)80179-5
  17. Akkan AG, Malaisse WJ (1994) Insulinotropic action of AICAriboside. I. Insulin release by isolated islets and the perfused pancreas. Diabetes Res 25:13–23
  18. Vincent M F, Bontemps F, Van den Berghe G, Inhibition of glycolysis by 5-amino-4-imidazolecarboxamide riboside in isolated rat hepatocytes, 10.1042/bj2810267
  19. Henin N, Vincent MF, Gruber HE, Van den Berghe G (1995) Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase. FASEB J 9:541–546
  20. Salmon D. Michael W., Bowen Neil L., Hems Douglas A., Synthesis of fatty acids in the perfused mouse liver, 10.1042/bj1420611
  21. Buchalter Scott E., Crain Michael R., Kreisberg Robert, Regulation of lactate metabolism in vivo, 10.1002/dmr.5610050405
  22. Rothman D., Magnusson I, Katz L., Shulman R., Shulman G., Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR, 10.1126/science.1948033
  23. Yki-Järvinen H, Helve E, Sane T, Nurjhan N, Taskinen MR (1989) Insulin inhibition of overnight glucose production and gluconeogenesis from lactate in NIDDM. Am J Physiol 256:E732-E739
  24. Backshear P J, Holloway P A H, Alberti K G M M, Metabolic interactions of dichloroacetate and insulin in experimental diabetic ketoacidosis. Studies on whole animals and after functional hepatectomy, 10.1042/bj1460447
  25. Pagliara Anthony S., Karl Irene E., Keating James P., Brown Barbara I., Kipnis David M., Hepatic fructose-1,6-diphosphatase deficiency, 10.1172/jci107018
  26. Morris A. A. M., Deshpande S., Ward-Platt M. P., Whitfield A. E., Aynsley-Green A., Leonard J. V., Pourfarzam M., Bartlett K., Impaired ketogenesis in fructose-1,6-bisphosphatase deficiency: a pitfall in the investigation of hypoglycaemia, 10.1007/bf00711369
  27. Gitzelmann R, Steinmann B, Van den Berghe G (1995) Disorders of fructose metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 7th edn. McGraw-Hill, New York, pp 905–934
  28. Sabina RL, Patterson D, Holmes EW (1985) 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. J Biol Chem 260:6107–6114
  29. Shafrir E, Berman M, Felig P (1986) The endocrine pancreas: diabetes mellitus. In: Felig P, Baxter JD, Broadus AE, Frohman LA (eds) Endocrinology and metabolism, 2nd edn. McGraw-Hill, New York, pp 1043–1178
  30. Consoli A., Nurjhan N., Capani F., Gerich J., Predominant Role of Gluconeogenesis in Increased Hepatic Glucose Production in NIDDM, 10.2337/diab.38.5.550
  31. Mitrakou Asimina, Kelley David, Mokan Marian, Veneman Thiemo, Pangburn Thomas, Reilly James, Gerich John, Role of Reduced Suppression of Glucose Production and Diminished Early Insulin Release in Impaired Glucose Tolerance, 10.1056/nejm199201023260104
  32. Nurjhan N, Consoli A, Gerich J, Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus., 10.1172/jci115558
  33. Magnusson I, Rothman D L, Katz L D, Shulman R G, Shulman G I, Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., 10.1172/jci115997